NRX Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wilmington, DE
NRXP chart
What traders are saying about $NRXP
Latest postsNRX Pharmaceuticals, Inc. news
- NRX Pharmaceuticals Inc (B1Q.HA) Stock Forum & Discussion - Yahoo Finance
Yahoo! Finance Canada ·
- NRX Pharmaceuticals Inc (B1Q.HA) Analyst Insights, Price Targets & Recommendations - Yahoo Finance
Yahoo! Finance Canada ·
- NRX Pharmaceuticals Inc (B1Q.HA) recent insider transactions
Yahoo Finance UK ·
- NRX Pharmaceuticals Inc (B1Q.HA) stock price, news, quote and history
Yahoo Finance Singapore ·
- NRX Pharmaceuticals Inc (B1Q.HA) latest stock news and headlines
Yahoo Finance UK ·
- NRX Pharmaceuticals Inc (B1Q.HA) valuation measures and financial statistics
Yahoo Finance UK ·
- NRX Pharmaceuticals Inc (B1Q.HA) income statement
Yahoo Finance UK ·
- Form DEF 14A NRX Pharmaceuticals Inc For: 5 November By Investing.com
Investing.com Canada ·
- Form 4 NRX Pharmaceuticals Inc: Jonathan C. Javitt (Director, CEO and Chairman) For: 28 July
Investing.com Nigeria ·
- A 75,000-unit CFO grant at NRX Pharmaceuticals (NRXP) vests annually in 2027–29 if service continues.
Stock Titan ·
- 150,000 stock units granted to NRX Pharmaceuticals (NRXP) CEO Javitt vest annually, subject to service.
Stock Titan ·
- NRx Pharmaceuticals Wins FDA Approval for Preservative-Free Ketamine Injection
marketbeat.com ·
NRX Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.2M | $0 | – | – |
| Net income | -$28.6M | -$25.1M | -$30.1M | -$39.8M |
| Diluted EPS | – | – | – | $-0.60 |
| Total assets (year end) | $13.0M | $3.7M | $7.3M | $25.8M |
| Cash and equivalents (year end) | $7.8M | $1.4M | $4.6M | $20.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About NRX Pharmaceuticals, Inc.
- Ticker
- NRXP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wilmington, DE
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1719406
- Former names
- Big Rock Partners Acquisition Corp.
Frequently asked questions
What exchange is NRX Pharmaceuticals, Inc. listed on?
NRX Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol NRXP.
What industry is NRX Pharmaceuticals, Inc. in?
NRX Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is NRX Pharmaceuticals, Inc. headquartered?
NRX Pharmaceuticals, Inc.'s business address on file with the SEC is in Wilmington, DE.
When does NRX Pharmaceuticals, Inc.'s fiscal year end?
NRX Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did NRX Pharmaceuticals, Inc. report?
NRX Pharmaceuticals, Inc. reported $1.2M in revenue for calendar year 2025, according to its SEC filings.